PSG Invests in DoseSpot

January 25, 2022

PSG, a growth equity firm, has made a growth investment in DoseSpot, a Dedham, Massachusetts–based SaaS e-prescribing platform. The capital will be used to accelerate product and go-to-market efforts, expand customer support, and grow DoseSpot's user base; financial terms were not disclosed.

Buyers
PSG
Targets
DoseSpot
Industry
Cloud & SaaS
Location
Massachusetts, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.